Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Utrophin is a homologue of dystrophin, the protein whose absence is responsible for Duchenne muscular dystrophy (DMD). As a first step toward clarifying if adenovirus (AV)-mediated utrophin transfer is a possible option to treat DMD, we have constructed an AV expressing utrophin (AdCMV-Utr) and studied utrophin expression after intramuscular injection of mdx mice, the mouse DMD model. Overexpression of utrophin by AdCMV-Utr was marked and nontoxic. The recombinant utrophin was distributed homogeneously at the surface of the muscle fibers. Its expression was sufficient to restore the normal histochemical pattern of alpha-sarcoglycan and beta-dystroglycan at this site. These two proteins are members of the dystrophin associated protein complex whose distribution is greatly reduced at the surface of the DMD muscle. These data indicate that AV-mediated utrophin transfer is an efficient way of utrophin upregulation in muscle and has the potential of becoming a treatment for DMD.

Original publication

DOI

10.1006/bbrc.1997.7936

Type

Journal article

Journal

Biochem Biophys Res Commun

Publication Date

06/01/1998

Volume

242

Pages

244 - 247

Keywords

Adenoviridae, Animals, Cytoskeletal Proteins, Gene Transfer Techniques, Genetic Therapy, Genetic Vectors, Injections, Intramuscular, Membrane Proteins, Mice, Mice, Inbred mdx, Muscle, Skeletal, Muscular Dystrophy, Animal, Recombinant Proteins, Utrophin